A Sad May for SPACs thestreet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestreet.com Daily Mail and Mail on Sunday newspapers.
ARS Pharmaceuticals Strengthens Board of Directors with Appointment of Industry Leader and Innovator Brent Saunders
News provided by
Share this article
Share this article
SAN DIEGO, May 13, 2021 /PRNewswire/ ARS Pharmaceuticals, Inc., a pharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect themselves from severe allergic reactions potentially leading to anaphylaxis, today announced the appointment of biotech leader and visionary Brent Saunders to its Board of Directors. Mr. Saunders currently serves as chief executive officer, president and chairman of Vesper Healthcare Acquisition Corp., a special purpose acquisition corporation, and previously served as Chairman and CEO of Allergan plc.
What s Next for SPACs
With prices, mood, interest, IPO valuation, and deal valuations all coming down, SPAC investors are asking what comes next.
Author:
SPACs joined Tuesday s tech selloff with the average price of a pre-deal SPAC hitting $9.90 that s 10 cents below NAV. It s ironic that in a SPAC market that is much more rational (and tradable) than during peak SPAC earlier this year investors have lost much of their enthusiasm.
Volume across the board has gone down for SPACs with an
average daily volume dropping from 580,000 in February dropping to 104,000 in April. In some ways this is good as the higher volumes were partly a sign of some irrational SPAC exuberance, but at these levels investors will be very worried about efficiently pricing as they get in / out of SPACs.
Linden and DW Healthcare Partners Complete HydraFacial s Public Offering via SPAC Merger
News provided by
Share this article
Share this article
CHICAGO and PARK CITY, Utah, May 5, 2021 /PRNewswire/ Linden Capital Partners ( Linden ) and DW Healthcare Partners IV, LP ( DW Healthcare Partners ), both private equity firms focused exclusively on the healthcare sector, announced today the completion of the merger of Edge Systems, LLC ( HydraFacial ), a category-creating beauty health company, with Vesper Healthcare Acquisition Corp. (NASDAQ: VSPR) ( Vesper or Vesper Healthcare ). Vesper is a special purpose acquisition company ( SPAC ) led by former Allergan CEO Brent Saunders. As a result of the transaction, the combined company, now known as The Beauty Health Company ( BeautyHealth or the Company ), is expected to trade on the Nasdaq Stock Market under the ticker symbol SKIN beginning May 6, 2021. Linden will remain BeautyHealth s largest shareholder.
Warren Buffett Piles on SPACs and CF Finance Lowers Deal Valuation
It was a bad day for SPACs as Warren Buffett piled on SPACs; CF Finance lowered their deal valuation with AEye; and today s MAAC deal had no pop.
Author:
May 3, 2021
Stocks were mixed on Monday, the S&P500 was up / NASDAQ down, though this morning s SPAC M&A deal (MAAC) once again underperformed. MAAC closed up just 0.9% and below NAV at $9.95 marking yet another disappointing day-1 pop for newly announced SPAC M&A.
Warren Buffett and Charlie Munger held Berkshire Hathaway s much watched virtual annual meeting over the weekend, and one of the talks of the town today (aside from naming his CEO successor) was his view on killer SPACs: